Navigation Links
How sneaky HIV escapes cells

Like hobos on a train, HIV, the virus that causes AIDS, uses a pre-existing transport system to leave one infected cell and infect new ones, Hopkins scientists have discovered. Their findings, published in the June issue of Plos Biology, counter the prevailing belief that HIV and other retroviruses can only leave and enter cells by virus-specific mechanisms.

“It appears that cells make HIV and other retroviruses by a naturally occurring export mechanism,” says Stephen Gould, Ph.D., Professor of Biological Chemistry at Johns Hopkins. Cells normally export certain membrane-bound molecules to the outside world by means of small sacs known as exosomes. By studying human T-cells under a microscope, Gould, Yi Fang, Ning Wu, and other members of his team discovered what’s needed to qualify proteins for exosomal travel.

“Surprisingly, all that’s needed for a protein to get out of the cell in exosomes are the ability to clump together and attach to the cell’s membrane,” Gould says.

In one experiment, Gould and his team added chemicals to normal human cells that force nearby proteins together into a clump, and this was enough to get them sent out of the cell in exosomes. If they added a tether to force naturally-clumping proteins inside the cell to the membrane, the proteins met a similar exosomal deportation fate.

The major HIV protein ‘Gag’ has both of these properties that cells sense in selecting exosomal cargoes. When the researchers removed the tethers or clumping signals from Gag it could no longer get out of the cell. However, if they were replaced with synthetic membrane anchors and clumping domains Gag regained its ability to get out of cells in exosomes.

Gould speculates that cells may have initially developed exosomes as a quality control mechanism to get rid of clumped proteins, which are generally broken and useless. However, just as retroviruses exploit other cell processes for their own ends, it now appear s they rely on exosomes to get out of infected cells and infect fresh cells. As such, drugs that interfere with exosome formation might be one way to inhibit HIV infections.

“Viruses like HIV use pathways we barely recognize, much less understand,” Gould says. “Our paper highlights the importance of studying their basic biochemistry and cell biology, which can yield a better understanding of normal human biology as well as identify new avenues in the fight against human disease.”


'"/>

Source:Johns Hopkins Medical Institutions


Related biology news :

1. Movie spies on malaria parasites sneaky behavior
2. Wisconsin scientists grow critical nerve cells
3. Spleen may be source of versatile stem cells
4. Researchers discover way to make cells in the eye sensitive to light
5. Priming embryonic stem cells to fulfill their promise
6. Lack of enzyme turns fat cells into fat burners
7. Poor prenatal nutrition permanently damages function of insulin-producing cells in the pancreas
8. Elusive HIV shape change revealed; Key clue to how virus infects cells
9. Mouse brain cells rapidly recover after Alzheimers plaques are cleared
10. Enzyme allows B cells to resist death, leading to leukemia
11. Scientists rid stem cell culture of key animal cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/20/2017)... July 20, 2017 Delta (NYSE: DAL ) customers ... Delta aircraft at Reagan Washington National Airport (DCA). ... Delta launches biometrics to board aircraft ... Delta,s biometric boarding pass ... is now integrated into the boarding process to allow eligible Delta ...
(Date:6/14/2017)... June 15, 2017  IBM (NYSE: IBM ) is introducing ... event dedicated to developing collaboration between startups and global businesses, ... 15-17. During the event, nine startups will showcase the solutions ... various industries. France ... market, with a 30 percent increase in the number of ...
(Date:5/16/2017)...   Bridge Patient Portal , an enterprise ... EMR Systems , an electronic medical record solutions ... established a partnership to build an interface between ... Centricity™ products, including Centricity Practice Solution (CPS), Centricity ... new integrations will allow healthcare delivery networks using ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... States multicenter, prospective clinical study that demonstrates the accuracy of the FebriDx® ... identifying clinically significant acute bacterial and viral respiratory tract infections by testing ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity of ... performing systematic gain-of-function studies. , This complement to loss-of-function studies, such as ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017  SkylineDx ... London (ICR) and University of Leeds ... to risk-stratify patients with multiple myeloma (MM), in a multi-centric ... The University of Leeds is the ... UK, and ICR will perform the testing services to include ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
Breaking Biology Technology: